Bispecific Antibody Receives FDA Fast Track Designation for Small Cell Lung Cancer
Fast track designation has been granted by the FDA to PT217 for extensive stage small cell lung cancer with disease progression.
Fast track designation has been granted by the FDA to PT217 for extensive stage small cell lung cancer with disease progression.
Patients who underwent extended lymph node dissection during radical cystectomy compared with those who underwent standard lymph node dissection exhibited no benefit in disease-free survival…
Data support using 18F-PSMA-1007 PET/CT in the preoperative workflow of intermediate- and high-risk prostate cancer.
In this issue of Blood, Fuchs et al1 have used T-cell biology, coupled with Genome Wide Association Studies (GWAS) and computational leverage of public dat
Ascites are abnormal pockets of fluid that develop in the abdomen. We spoke to gynecologic oncologist Travis Sims, M.D., to learn more about this late-stage…
Joshua Richter, MD, FACP, presents recent National Comprehensive Cancer Network (NCCN) guideline updates in the treatment of multiple myeloma.
If you’re carrying excess weight, those extra pounds can affect many areas of your health, including your risk for cancer. In fact, being overweight or…
Outcome improvements with lutetium Lu 177 vipivotide tetraxetan vs ARPI change favored prior treatment with abiraterone vs enzalutamide in mCRPC.
18F-PSMA-1007 PET/CT generated superior locoregional staging results vs multiparametric MRI in patients with prostate cancer.
Physicians’ Education Resource – Newest Continuing Medical Education Live Events, Webcasts & Online Activities
Take this survey powered by surveymonkey.com. Create your own surveys for free.